Weight loss results vary by drug, with Rybelsus producing more modest losses (~6% in a year) and Foundayo and Wegovy producing results on par with injections (up to ~11%--14% in a year, respectively)
The number of cases has doubled over the last decade
Semaglutide 0.50 mg The Acceleration Dose for Weight Loss Stronger appetite control
Intermittent Protocols Because rebound is predictable and individual, your healthcare provider should help you evaluate whether continuous semaglutide use, dose adjustments, or structured breaks align with your metabolic profile, treatment goals, and medical history
Patients with a history of bariatric surgery (a risk factor for hypoglycemia) had more events of serious hypoglycemia while taking WEGOVY (2.3%, 2/87) than placebo (0%, 0/97)